Efficacy and safety data from patients with advanced squamous NSCLC and brain metastases participating in the nivolumab Expanded Access Programme (EAP) in Italy

P. Bidoli; R. Chiari; A. Catino; F. Grossi; C. Noberasco; F. Gelsomino; M. Gilli; C. Proto; H. J.Soto Parra; M. R. Migliorino; L. Bonomi; D. Tassinari; A. Frassoldati; V. Albanese; G. M. Fadda; F. Cognetti; F. de galitiis; G. Finocchiaro; A. Delmonte

doi:10.1093/annonc/mdw383.28

Efficacy and safety data from patients with advanced squamous NSCLC and brain metastases participating in the nivolumab Expanded Access Programme (EAP) in Italy

P. Bidoli, R. Chiari, A. Catino, F. Grossi, C. Noberasco, F. Gelsomino, M. Gilli, C. Proto, H. J.Soto Parra, M. R. Migliorino, L. Bonomi, D. Tassinari, A. Frassoldati, V. Albanese, G. M. Fadda, F. Cognetti, F. de galitiis, G. Finocchiaro, A. Delmonte

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	vi425
Journal	Annals of Oncology
Volume	27
DOIs	https://doi.org/10.1093/annonc/mdw383.28
Publication status	Published - Oct 1 2016

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdw383.28

Cite this

Bidoli, P., Chiari, R., Catino, A., Grossi, F., Noberasco, C., Gelsomino, F., Gilli, M., Proto, C., Parra, H. J. S., Migliorino, M. R., Bonomi, L., Tassinari, D., Frassoldati, A., Albanese, V., Fadda, G. M., Cognetti, F., de galitiis, F., Finocchiaro, G., & Delmonte, A. (2016). Efficacy and safety data from patients with advanced squamous NSCLC and brain metastases participating in the nivolumab Expanded Access Programme (EAP) in Italy. Annals of Oncology, 27, vi425. https://doi.org/10.1093/annonc/mdw383.28

Efficacy and safety data from patients with advanced squamous NSCLC and brain metastases participating in the nivolumab Expanded Access Programme (EAP) in Italy. / Bidoli, P.; Chiari, R.; Catino, A.; Grossi, F.; Noberasco, C.; Gelsomino, F.; Gilli, M.; Proto, C.; Parra, H. J.Soto; Migliorino, M. R.; Bonomi, L.; Tassinari, D.; Frassoldati, A.; Albanese, V.; Fadda, G. M.; Cognetti, F.; de galitiis, F.; Finocchiaro, G.; Delmonte, A.

In: Annals of Oncology, Vol. 27, 01.10.2016, p. vi425.

Research output: Contribution to journal › Article › peer-review

Bidoli, P, Chiari, R, Catino, A , Grossi, F, Noberasco, C, Gelsomino, F, Gilli, M, Proto, C, Parra, HJS, Migliorino, MR, Bonomi, L, Tassinari, D, Frassoldati, A, Albanese, V, Fadda, GM, Cognetti, F , de galitiis, F , Finocchiaro, G & Delmonte, A 2016, 'Efficacy and safety data from patients with advanced squamous NSCLC and brain metastases participating in the nivolumab Expanded Access Programme (EAP) in Italy', Annals of Oncology, vol. 27, pp. vi425. https://doi.org/10.1093/annonc/mdw383.28

Bidoli, P. ; Chiari, R. ; Catino, A. ; Grossi, F. ; Noberasco, C. ; Gelsomino, F. ; Gilli, M. ; Proto, C. ; Parra, H. J.Soto ; Migliorino, M. R. ; Bonomi, L. ; Tassinari, D. ; Frassoldati, A. ; Albanese, V. ; Fadda, G. M. ; Cognetti, F. ; de galitiis, F. ; Finocchiaro, G. ; Delmonte, A. / Efficacy and safety data from patients with advanced squamous NSCLC and brain metastases participating in the nivolumab Expanded Access Programme (EAP) in Italy. In: Annals of Oncology. 2016 ; Vol. 27. pp. vi425.

@article{d494168205214bc1b9d6134e08903b57,

title = "Efficacy and safety data from patients with advanced squamous NSCLC and brain metastases participating in the nivolumab Expanded Access Programme (EAP) in Italy",

author = "P. Bidoli and R. Chiari and A. Catino and F. Grossi and C. Noberasco and F. Gelsomino and M. Gilli and C. Proto and Parra, {H. J.Soto} and Migliorino, {M. R.} and L. Bonomi and D. Tassinari and A. Frassoldati and V. Albanese and Fadda, {G. M.} and F. Cognetti and {de galitiis}, F. and G. Finocchiaro and A. Delmonte",

year = "2016",

month = oct,

day = "1",

doi = "10.1093/annonc/mdw383.28",

language = "English",

volume = "27",

pages = "vi425",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "NLM (Medline)",

}

TY - JOUR

T1 - Efficacy and safety data from patients with advanced squamous NSCLC and brain metastases participating in the nivolumab Expanded Access Programme (EAP) in Italy

AU - Bidoli, P.

AU - Chiari, R.

AU - Catino, A.

AU - Grossi, F.

AU - Noberasco, C.

AU - Gelsomino, F.

AU - Gilli, M.

AU - Proto, C.

AU - Parra, H. J.Soto

AU - Migliorino, M. R.

AU - Bonomi, L.

AU - Tassinari, D.

AU - Frassoldati, A.

AU - Albanese, V.

AU - Fadda, G. M.

AU - Cognetti, F.

AU - de galitiis, F.

AU - Finocchiaro, G.

AU - Delmonte, A.

PY - 2016/10/1

Y1 - 2016/10/1

UR - http://www.scopus.com/inward/record.url?scp=85081690724&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081690724&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdw383.28

DO - 10.1093/annonc/mdw383.28

M3 - Article

VL - 27

SP - vi425

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

ER -

Efficacy and safety data from patients with advanced squamous NSCLC and brain metastases participating in the nivolumab Expanded Access Programme (EAP) in Italy

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this